Skip to content
value.today
Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI
$304 Mmarket cap on Oct 20, 2026-10.8% since Jan 2024
Compare
World rank
#14,719
Revenue
$103 M
For year ending December-2025
Net income
$-38 M
-36.4% margin
SEC filing
Employees
—

Sanara MedTech Inc. in brief

Sanara MedTech Inc. is a listed company in the Medical Care Facilities industry, based in Fort Worth, Texas, USA. Its market value was $304 M on 20 October 2026, which makes it the 14,719th largest listed company in the world and the 2,864th largest in the USA on this site. In the year to December 2025 it had sales of $103 M and a net loss of $38 M. Seth D. Yon is its chief executive. Its largest product and service lines by sales in 2025 were Soft Tissue Repair Products (89%) and Bone Fusion Products (11%). Its shares trade under the symbol SMTI (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Sanara MedTech Inc.

We are a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. Our products are designed to achieve our goal of providing better clinical outcomes at a lower overall cost for healthcare systems. We strive to be one of the most innovative and comprehensive providers of effective surgical solutions and are continually seeking to expand our offerings for patients requiring surgical treatments in the United States.

We primarily market and sell soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Our soft tissue repair products include, among other products, our lead product, CellerateRX Surgical Powder, a hydrolyzed collagen that aids in the management of surgical wounds, and BIASURGE Advanced Surgical Solution, a sterile no-rinse, advanced surgical solution used for wound irrigation. Our bone fusion products include, among other products, BiFORM Bioactive Moldable Matrix, an osteoconductive, bioactive, porous implant that allows for bony ingrowth across the graft site, and ALLOCYTE Plus Advanced Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

From the company's annual report filed with the US SEC: read the report

Sanara MedTech Inc. timeline

6 events, 1996–2025
  1. 1996
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. ✎
    Renamed Mb Software Corp
    Formerly Inav Travel Corporation.
  4. 2008
  5. ✎
    Renamed Wound Management Technologies, Inc.
    Formerly Mb Software Corp.
  6. 2019
  7. ✎
    Renamed Sanara MedTech Inc.
    Formerly Wound Management Technologies, Inc..
  8. 2025
  9. 💰
    Record revenue of $103 million
    FY2025, the highest of the 8 years on record.
  10. 💰
    Record net income of $38 million
    FY2025, the highest profit of the 3 years on record.

Events of Sanara MedTech Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$96 M$192 M$288 M$383 M2020202120222023202420252026

World rank over time

▲ up 6,855 places since 2020
2020-01-01: #21609#21,60920202021-01-01: #13456#13,45620212022-01-07: #18692#18,69220222022-12-25: #14660#14,66020222023-07-30: #15105#15,10520232024-01-05: #14979#14,97920242026-03-08: #9229#9,22920262026-08-01: #14017#14,01720262026-10-07: #14576#14,57620262026-10-20: #14754#14,7542026

Rank in USA: #4,076 (Jan 2020) · #2,915 (Jan 2021) · #3,783 (Jan 2022) · #3,003 (Dec 2022) · #3,063 (Jul 2023) · #2,825 (Jan 2024) · #1,771 (Mar 2026) · #2,835 (Aug 2026) · #2,824 (Oct 2026) · #2,868 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
2.7×
Price / book
51.2×
Free cash flow yield
0.7%
Net margin (TTM)
-2.7%
Operating margin
7.1%
Return on equity
-50.7%
Liabilities / assets
91.9%
Net debt
$29M
Revenue growth
+19.0%
R&D / revenue
4.9%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $6M, net income $-1M$6MFY18Fiscal year ending Dec 2019: revenue $12M, net income $-3M$12MFY19Fiscal year ending Dec 2020: revenue $16M, net income $-4M$16MFY20Fiscal year ending Dec 2021: revenue $24M, net income $-8M$24MFY21Fiscal year ending Dec 2022: revenue $46M, net income $-8M$46MFY22Fiscal year ending Dec 2023: revenue $65M, net income $-4M$65MFY23Fiscal year ending Dec 2024: revenue $87M, net income $-10M$87MFY24Fiscal year ending Dec 2025: revenue $103M, net income $-38M$103MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$103M+19.0%$7M$-38M-36.4%
Dec 2024$87M+33.4%$1M$-10M-11.1%
Dec 2023$65M+41.8%$-4M$-4M-6.6%
Dec 2022$46M+89.9%$-13M$-8M-17.3%
Dec 2021$24M+54.8%$-7M$-8M-32.8%
Dec 2020$16M+32.5%$-5M$-4M-28.5%
Dec 2019$12M+101.5%$-3M$-3M-23.9%
Dec 2018$6M—$-1M$-1M-10.3%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$7M$5M$2M$-4.36—
Dec 2024$-0M$0M$-0M$-1.14—
Dec 2023$-3M$0M$-4M$-0.52—
Dec 2022$-6M$0M$-6M$-1.00—
Dec 2021$-5M$0M$-5M$-1.08—
Dec 2020$-4M$1M$-5M$-0.76—
Dec 2019$-2M$0M$-2M$-1.32—
Dec 2018$0M$0M$0M$0.00—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$112M
Net income, trailing 12 months
$-3M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $26M, net income $-2M$26MDec ’24Three months to Mar 2025: revenue $23M, net income $-4M$23MMar ’25Three months to Jun 2025: revenue $26M, net income $-2M$26MJun ’25Three months to Sep 2025: revenue $26M, net income $-30M$26MSep ’25Three months to Dec 2025 (from the annual report): revenue $28M, net income $-2M$28MDec ’25Three months to Mar 2026: revenue $28M, net income $0M$28MMar ’26Three months to Jun 2026: revenue $28M, net income $-0M$28MJun ’26Three months to Sep 2026: revenue $28M, net income $-1M$28MSep ’26

Latest quarter to Sep 2026: revenue $28M (+8.0% on a year earlier), net income $-1M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Sanara MedTech Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$103 M
Operating income
$7 M
Net income
$-38 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$73 M
Total liabilities
$67 M
Total equity
$6 M

As of December-2025

Top 84 institutional investors in Sanara MedTech Inc.#

As of Sep 30, 2026
84 institutions held 3.0 M shares (about 32.6% of the shares outstanding) on Sep 30, 2026. The ten largest hold 20.6%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Sanara MedTech Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.429,517+180,690 (+72.62%)4.68%$15 MNov 13, 2026
2Glazer Capital, LLC349,684New3.81%$12 MNov 17, 2026
3Vanguard Capital Management LLC194,8970 (0.00%)2.12%$7 MNov 13, 2026
4Qube Research & Technologies Ltd176,318+155,918 (+764.30%)1.92%$6 MNov 13, 2026
5Transmarket Holdings LP148,956New1.62%$5 MOct 27, 2026
6Abc Arbitrage SA140,894New1.53%$5 MOct 23, 2026
7Toronto Dominion Bank119,900New1.31%$4 MNov 16, 2026
8Renaissance Technologies LLC114,100+46,700 (+69.29%)1.24%$4 MNov 12, 2026
9Gardner Lewis Asset Management L P112,461New1.22%$4 MNov 13, 2026
10Geode Capital Management, LLC105,346+16,167 (+18.13%)1.15%$4 MNov 6, 2026
11Alberta Investment Management Corp102,400New1.12%$4 MNov 9, 2026
12Polar Asset Management Partners Inc.82,182New0.90%$3 MNov 16, 2026
13State Street Corp68,241+4,772 (+7.52%)0.74%$2 MNov 12, 2026
14Sagefield Capital LP65,782New0.72%$2 MNov 16, 2026
15ExodusPoint Capital Management, LP53,605New0.58%$2 MNov 16, 2026
16Morgan Stanley46,044+22,416 (+94.87%)0.50%$2 MNov 13, 2026
17D. E. Shaw & Co., Inc.45,741+29,371 (+179.42%)0.50%$2 MNov 16, 2026
18Northern Trust Corp44,266+7,825 (+21.47%)0.48%$2 MNov 16, 2026
19Millennium Management LLC36,990New0.40%$1 MNov 16, 2026
20Royal Bank Of Canada35,143-95,852 (-73.17%)0.38%$1 MNov 16, 2026
21Vanguard Portfolio Management LLC33,852+10,435 (+44.56%)0.37%$1 MNov 13, 2026
22FMR LLC29,616+28,489 (+2527.86%)0.32%$1 MNov 10, 2026
23Goldman Sachs Group Inc28,998-45,200 (-60.92%)0.32%$1 MNov 16, 2026
24Vanguard Fiduciary Trust Co28,899+2,872 (+11.03%)0.31%$1 MNov 13, 2026
25Natixis28,839New0.31%$1 MNov 6, 2026
Show all 84: investors 26 to 84
Institutional investors 26 to 84 in Sanara MedTech Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Russell Investments Group, Ltd.26,285+25,309 (+2593.14%)0.29%$1 MNov 6, 2026
27Jane Street Group, LLC26,222-24,584 (-48.39%)0.29%$1 MNov 12, 2026
28Credit Industriel Et Commercial26,183New0.29%$1 MNov 13, 2026
29AQR Capital Management LLC25,965-86,242 (-76.86%)0.28%$1 MNov 16, 2026
30Hill Island Financial LLC24,291New0.26%$1 MOct 20, 2026
31Price T Rowe Associates Inc /MD/20,214+962 (+5.00%)0.22%$1 MNov 16, 2026
32Rockefeller Capital Management L.P.18,742+4,349 (+30.22%)0.20%$1 MNov 13, 2026
33Jump Financial, LLC17,000New0.19%$1 MNov 13, 2026
34Bank of New York Mellon Corp16,061New0.17%$1 MNov 5, 2026
35Dimensional Fund Advisors LP15,748+6,372 (+67.96%)0.17%$1 MNov 4, 2026
36Water Island Capital LLC14,601New0.16%$1 MNov 13, 2026
37Charles Schwab Investment Management Inc13,473+3,463 (+34.60%)0.15%$0 MNov 16, 2026
38Carlson Capital, L.P.13,300New0.14%$0 MNov 9, 2026
39Nuveen, LLC11,529+428 (+3.86%)0.13%$0 MNov 10, 2026
40Janney Montgomery Scott LLC10,030-7,500 (-42.78%)0.11%$0 MNov 12, 2026
41Two Sigma Investments, LP9,678New0.11%$0 MNov 16, 2026
42Citigroup Inc8,687+4,671 (+116.31%)0.09%$0 MNov 4, 2026
43Mint Tower Capital Management B.V.8,462New0.09%$0 MNov 9, 2026
44American Century Companies Inc7,411New0.08%$0 MNov 12, 2026
45State Board Of Administration Of Florida Retirement System7,100New0.08%$0 MNov 13, 2026
46Bank Of America Corp /de/6,336-9,609 (-60.26%)0.07%$0 MNov 16, 2026
47Wealthspire Advisors, LLC6,109New0.07%$0 MNov 13, 2026
48Canada Pension Plan Investment Board5,800New0.06%$0 MNov 16, 2026
49Rhumbline Advisers4,651+2,101 (+82.39%)0.05%$0 MNov 10, 2026
50UBS Group AG4,635+4,279 (+1201.97%)0.05%$0 MNov 10, 2026
51Deutsche Bank AG\3,591-552 (-13.32%)0.04%$0 MNov 6, 2026
52MetLife Investment Management, LLC3,040New0.03%$0 MNov 16, 2026
53New York State Common Retirement Fund2,4330 (0.00%)0.03%$0 MNov 17, 2026
54Jpmorgan Chase & Co2,401-229 (-8.71%)0.03%$0 MNov 12, 2026
55MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2,334+781 (+50.29%)0.03%$0 MNov 16, 2026
56Barclays PLC2,116-157 (-6.91%)0.02%$0 MNov 6, 2026
57Vanguard Global Advisers, LLC1,786+881 (+97.35%)0.02%$0 MNov 13, 2026
58Wells Fargo & Company/mn1,482-1,597 (-51.87%)0.02%$0 MNov 16, 2026
59Police & Firemen's Retirement System of New Jersey1,359+576 (+73.56%)0.01%$0 MNov 9, 2026
60BNP Paribas Financial Markets1,335-12,904 (-90.62%)0.01%$0 MNov 12, 2026
61Arax Advisory Partners635-672 (-51.42%)0.01%$0 MNov 12, 2026
62Legal & General Group Plc426+143 (+50.53%)0.00%$0 MNov 16, 2026
63Tower Research Capital LLC (TRC)386-449 (-53.77%)0.00%$0 MNov 16, 2026
64Ameritas Investment Partners, Inc.3130 (0.00%)0.00%$0 MNov 13, 2026
65UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC222New0.00%$0 MNov 16, 2026
66Osaic Holdings, Inc.1880 (0.00%)0.00%$0 MNov 12, 2026
67Sterling Capital Management LLC161+149 (+1241.67%)0.00%$0 MOct 22, 2026
68GAMMA Investing LLC800 (0.00%)0.00%$0 MOct 8, 2026
69Mather Group, LLC.69New0.00%$0 MOct 14, 2026
70SJS Investment Consulting Inc.65+58 (+828.57%)0.00%$0 MOct 26, 2026
71Spire Wealth Management600 (0.00%)0.00%$0 MOct 30, 2026
72IFP Advisors, Inc51-31 (-37.80%)0.00%$0 MOct 16, 2026
73Allworth Financial LP48-108 (-69.23%)0.00%$0 MNov 17, 2026
74Parkside Financial Bank & Trust45New0.00%$0 MOct 27, 2026
75California State Teachers Retirement System430 (0.00%)0.00%$0 MNov 13, 2026
76Essential Partners LLC39-75 (-65.79%)0.00%$0 MOct 14, 2026
77Global Retirement Partners, LLC38New0.00%$0 MNov 10, 2026
78Root Financial Partners, LLC38New0.00%$0 MOct 21, 2026
79True Wealth Design, LLC35-32 (-47.76%)0.00%$0 MOct 13, 2026
80EverSource Wealth Advisors, LLC30-124 (-80.52%)0.00%$0 MNov 4, 2026
81Caitong International Asset Management Co., Ltd23New0.00%$0 MOct 29, 2026
82PNC Financial Services Group, Inc.18New0.00%$0 MNov 6, 2026
83Farther Finance Advisors, LLC18-32 (-64.00%)0.00%$0 MOct 8, 2026
84Rothschild Investment LLC9-26 (-74.29%)0.00%$0 MNov 10, 2026

Mutual funds holding Sanara MedTech Inc.#

69 funds hold shares worth $12 M (about 5.4% of the company). Since their previous reports 30 added shares and 13 sold, buying $2 M net.
Mutual funds holding Sanara MedTech Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.148,899$4 M1.6%<0.01%+41%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors74,682$2 M0.81%<0.01%−4.4%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC36,350$1 M0.40%<0.01%+21%Jul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.42,865$1 M0.47%<0.01%−0.3%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors31,668$1 M0.34%<0.01%+30%Jun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC19,525$0 M0.21%<0.01%+1.0%May 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC11,038$0 M0.12%0.04%newJul 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.15,524$0 M0.17%<0.01%+2.9%May 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.8,345$0 M0.09%<0.01%+44%Jul 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors11,230$0 M0.12%0.02%+43%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.9,609$0 M0.10%<0.01%+60%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC5,089$0 M0.06%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC6,529$0 M0.07%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC5,716$0 M0.06%<0.01%+11%May 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP3,812$0 M0.04%<0.01%newJul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC5,191$0 M0.06%<0.01%no changeJun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC5,177$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC3,962$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP2,700$0 M0.03%<0.01%newJul 31, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC3,200$0 M0.03%<0.01%+40%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.2,941$0 M0.03%<0.01%+2.9%May 31, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC2,800$0 M0.03%<0.01%+7.5%May 31, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.2,404$0 M0.03%0.01%−4.6%Jun 30, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.1,654$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Venerable US Small Cap FundVenerable Investment Advisers, LLC2,346$0 M0.03%0.03%−2.9%Jun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC1,600$0 M0.02%<0.01%+16%Jul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC2,210$0 M0.02%<0.01%+46%Jun 30, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.2,135$0 M0.02%<0.01%+1.3%May 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation1,900$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.1,854$0 M0.02%<0.01%−39%Jun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.1,830$0 M0.02%<0.01%−11%Jun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC1,630$0 M0.02%<0.01%+75%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC1,600$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.1,279$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company1,121$0 M0.01%<0.01%no changeMay 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.1,000$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC615$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC878$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP605$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 U.S. Small Cap Growth PortfolioDimensional Fund Advisors LP586$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.565$0 M<0.01%<0.01%+60%Jul 31, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC767$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC747$0 M<0.01%<0.01%+18%Jun 30, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP509$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP439$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC628$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust572$0 M<0.01%<0.01%newMay 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC549$0 M<0.01%<0.01%−94%Jun 30, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC345$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS487$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 TIAA Separate Account VA-1 - Stock Index AccountTeachers Advisors, LLC448$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.435$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC433$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC291$0 M<0.01%<0.01%−6.1%Jul 31, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.378$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC353$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management313$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.294$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC252$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS160$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC214$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC167$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC143$0 M<0.01%<0.01%+7.5%May 31, 2026
🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC129$0 M<0.01%<0.01%−9.8%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC112$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC114$0 M<0.01%<0.01%−39%May 31, 2026
🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC91$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC27$0 M<0.01%<0.01%+35%Jul 31, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.34$0 M<0.01%<0.01%−71%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 69 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Sanara MedTech Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
26
since
Sanara MedTech Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Seth D. YonChief Executive Officer, DirectorShares withheld for tax-3,661$35.11$129 K105,885Form 4
filed Sara N. OrtweinDirectorGrant or award+4,616——25,415Form 4
filed Eric D. TanzbergerDirectorGrant or award+5,308——22,966Form 4
filed Ronald T. NixonDirector, 10% ownerGrant or award+4,154——68,196Form 4
filed Roszell Mack IIIDirectorGrant or award+5,308——21,842Form 4
filed Eric D. MajorDirectorGrant or award+4,846——14,232Form 4
filed Robert Andrew DeSutterDirectorGrant or award+5,539——28,740Form 4
filed Keith G. MyersDirectorGrant or award+4,385——9,325Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Sanara MedTech Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
412,339
4.6% of shares · 3.24 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2026-07-29 18:21 UTC, code T3, resumed 20:30 UTC

Fails to deliver

  • : 16,834 shares at $33.14
  • : 10 shares at $35.09
  • : 10 shares at $35.00
  • : 5 shares at $35.14
  • : 668 shares at $35.10

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Sanara MedTech Inc. scorecard#

Passes 9 of the 23 checks that could be worked out: strongest in growth (4 of 6), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 20, 2026.

  • Valuation0 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' median51.2×Price to book 51.2× against Medical Care Facilities's median of 4.0×.
    • ✗Price to sales below its peers' median2.7×Price to sales 2.7× against Medical Care Facilities's median of 1.4×.
    • ✗Free cash flow yield above 5%0.7%Free cash flow is 0.7% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth4 of 6
    • ✓Revenue grew in the newest year19.0%Revenue up 19.0% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years31.0%31.0% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median31.0%31.0% a year against Medical Care Facilities's median of 9.0% (33 companies).
    • ✗Earnings per share grew in the newest year-4.36 vs -1.14Diluted EPS -4.36 in fiscal 2025 against -1.14 the year before (report's currency).
    • ✗Net income higher than five years earlier-$38 M-$38 M in fiscal 2025 against -$4 M in 2020.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
  • Profitability1 of 5
    • ✗Profitable in the newest year-$38 MNet income -$38 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median7.1%7.1% against Medical Care Facilities's median of 7.9% (36 companies).
    • ✗Return on equity above 15%-165.7%-165.7% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier7.1%7.1% in fiscal 2025 against -27.3% in 2022.
  • Financial health3 of 6
    • ✓Short-term assets cover short-term liabilities1.8×Current ratio 1.80 at the end of fiscal 2025.
    • ✗Debt below equity7.7×Debt to equity 7.74 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDA2.6×Net debt 2.6 times EBITDA in fiscal 2025.
    • ✗Operating income covers interest five times1.1×Operating income 1.1 times interest in fiscal 2025.
    • ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone3.27Z-score 3.27 (safe zone) for fiscal 2025.
  • Shareholder returns1 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year1.6%Diluted shares up 1.6% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Care Facilities, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Sanara MedTech Inc.'s statements, beside the median of Medical Care Facilities.

Sanara MedTech Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin7.1%7.9%
Net margin-36.4%3.2%
Return on equity-165.7%8.2%
Revenue growth, 3 years a year31.0%9.0%
Revenue growth19.0%6.7%
Debt to equity7.74×0.56×

4of 9on the Piotroski tests of financial strength

  • Net loss of $38 million, the 8th loss-making year in a row.
  • Operating income covers the interest bill only 1.1 times.
  • Goodwill and intangibles ($22 million) exceed shareholders' equity ($6 million).
  • Revenue has grown 7 years in a row.

Sanara MedTech Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Sanara MedTech Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue1038765462416125.86.35.5
Cost of revenue7.58.17.96.42.31.61.20.50.80.9
Gross profit967957392214115.35.54.6
Research and development5.12.8r4.13.40.60.0————
Selling, general and administrative7972r574628—————
Selling and marketing6256————————
General and administrative1715——2819r135.75.33.9
Operating expenses8877r6152r2919135.85.44.8
Operating income7.31.3r−4.2−13r−7.4−5.0−2.7−0.50.1−0.3
Interest and finance income———————−0.00.00.0
Interest expense and finance costs6.83.10.50.30.00.00.10.10.10.2
Share of profit of associates−1.0−0.1—−0.4−0.6——−0.00—
Other non-operating income (expense)−7.7−3.2−0.2−1.4r−0.60.6−0.1−0.10.2−0.1
Income before tax−0.4−1.9−4.4−14−8.0—————
Income tax—0.0r—−5.8—00000
Income from continuing operations−0.4−1.9———−4.4−2.8———
Income from discontinued operations−37−8.0————————
Net income including minority interests−38−9.9−4.4−8.1−8.0—————
Minority interests' share of net income−0.0−0.2−0.1−0.2−0.1−0.1−0.0———
Net income attributable to shareholders−38−9.7−4.3−7.9−7.9r−4.4r−2.8−0.60.3−0.4
Earnings per share, basic-4.36-1.14-0.52-1.00-1.08-0.76-1.320.000.00-0.01
Earnings per share, diluted-4.36-1.14-0.52-1.00-1.08-0.76-1.320.000.00-0.01
Shares, weighted average (basic)8.68.58.37.97.35.72.1217111109
Shares, weighted average (diluted)8.68.58.37.97.35.72.1217209109
Balance sheet
Cash and cash equivalents17165.19.0190.56.60.2r0.50.8
Receivables12——6.82.9r0————
Inventory3.92.84.73.52.01.10.70.5r0.70.3
Other current assets0.91.0r0.61.10.90.60.20.0r0.00.0
Current assets34331921254.58.91.7r2.02.0
Property, plant and equipment0.50.41.31.41.60.70.20.0r0.10.0
Right-of-use (leased) assets2.11.42.00.80.40.50.60——
Goodwill3.63.63.63.6——————
Other intangible assets1923r45324.73.11.50r0.10.1
Investments in associates145.2——————0—
Long-term investments156.2r3.13.15.01.10———
Non-current assets39555540125.32.30.0r0.20.2
Total assets73887461369.8111.7r2.22.2
Accounts payable2.3——1.40.40.30.30.2r0.20.2
Debt due within a year——0.6———0———
Current liabilities191514136.03.52.61.1r2.11.4
Long-term debt46319.1———————
Lease liabilities (non-current)1.91.21.70.50.20.40.50——
Non-current liabilities4834166.50.20.42.10r01.2
Total liabilities674929196.24.04.71.1r2.12.6
Retained earnings−75−38−28−23−15−7.0−2.70.1r−47−47
Shareholders' equity5.9394542316.2r6.4r0.6r0.1−0.4
Minority interests−0.0−0.5−0.2−0.1−0.5−0.3−0.20——
Total equity5.9394542305.8r6.40.6——
Total liabilities and equity73887461369.8111.7r2.22.2
Shares outstanding8.98.88.58.37.76.33.6—113110
Cash-flow statement
Depreciation and amortization3.94.93.72.40.60.30.10.10.10.1
Share-based compensation5.24.43.42.72.71.40———
Cash from operating activities6.8−0.0−3.2−5.6−4.8−4.0−2.20.3−0.10.4
Capital expenditure−4.6−0.2−0.3−0.1−0.2−0.5−0.2−0.0−0.0−0.0
Intangible assets bought−0.0−0.0—−0.6−0.6−1.1−1.50−0.00
Acquisitions, net of cash acquired——−9.9———————
Cash from investing activities−15−6.6−10−3.5−5.3−2.7−1.2−0.0−0.1−0.0
Debt issued—————0.6————
Cash from financing activities8.9179.6−0.6280.69.80−0.10.2
Change in cash0.711−3.8−9.718−6.26.4———
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Sanara MedTech Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Soft Tissue Repair Products$91 M89%
  • Bone Fusion Products$12 M11%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Executive pay at Sanara MedTech Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$2.3 M
Seth D. Yon
Other top executives, average
$740 K
the CEO earned 3.1× this
$100 invested is now
$51
Sanara MedTech Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Seth D. Yon$2.3 M$1.5 M$740 K$51
2024Seth D. Yon$1.7 M$1.2 M$524 K$112
2023Zachary B. Fleming$910 K$784 K$708 K$82

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Sanara MedTech Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Acquisition or sale completed 1 · Directors and officers 3 · Material agreement 4 · Agreement ended 1 · Shareholder vote 3 · Results announced 12

Sanara MedTech Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Shareholder vote8-K
Material agreement8-K/A
Results announced8-K
Material agreement8-K
Shareholder vote8-K
Agreement ended8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Shareholder vote8-K
Directors and officers8-K
Results announced8-K
Acquisition or sale completedMaterial agreement8-K
Results announced8-K
Material agreement8-K
Directors and officers8-K
Results announced8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026

Acquisitions and funding#

1 acquisitions, $3 M paid where reported

Businesses it acquired

Acquisitions by Sanara MedTech Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
Care PICS2025—$3 M—Annual report

Private share sales · funding history

Private share sales of Sanara MedTech Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2023$3 MPrivate placement after listing$2 to $10 million1equitySEC
Jul 2022$16 MPrivate placement after listing$10 to $50 million1equitySEC
Apr 2022$15 MPrivate placement after listing$10 to $50 million46equitySEC
Jan 2021$1 MPrivate placement after listingUnder $2 million2equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at Sanara MedTech Inc.#

1 labor condition applications certified in fiscal 2025 for 1 positions, at a median wage of $84 K a year.

Certified, FY2025
1
#1,903 among companies on value.today
Worker positions
1
Median wage offered
$84 K
a year, full-time
Applications filed
1
Sanara MedTech Inc.: most frequent H-1B job titles in fiscal 2025
Job titlePositionsMedian wage offered
Biomedical EngineerBioengineers and Biomedical Engineers1$84 K

Where: San Antonio, TX 1

Sanara MedTech Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202511$84 K1
FY202411$200 K1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Sanara MedTech Inc

How Sanara MedTech Inc. compares in Medical Care Facilities

  • Market cap$304 M · higher than 21% of 113
  • Revenue$103 M · higher than 14% of 131
  • Net margin-2.7% · higher than 12% of 127
  • Revenue growth19.0% · higher than 87% of 53
  • Price / sales2.7× · lower than 33% of 82
  • Price / book51.2× · lower than 3% of 71
  • FCF yield0.7% · higher than 28% of 33

Peer comparison · Medical Care Facilities

CompanyMarket capP/ENet marginRev. growth
Sanara MedTech Inc.🇺🇸$304 M—-2.7%+19.0%
HCA Healthcare, Inc.🇺🇸$96.8 B14.3×8.6%+7.1%
Fresenius SE & Co. KGaA🇩🇪$30.7 B20.4×5.5%-3.4%
Dr. Sulaiman Al Habib Medical Services Group Company🇸🇦$22.2 B34.6×17.5%+9.6%
Tenet Healthcare Corporation🇺🇸$21.4 B5.6×17.2%+3.1%
IHH Healthcare Berhad🇲🇾$18.1 B34.8×8.2%—
JD Health International Inc.🇨🇳$15.7 B20.2×7.3%—
Apollo Hospitals Enterprise Limited🇮🇳$13.5 B64.2×7.8%—
Fresenius Medical Care AG🇩🇪$12.4 B11.3×5.0%+5.8%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 20, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Sanara MedTech Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Sanara MedTech Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Sanara MedTech Inc.? Suggest a correction